CompletedPHASE1, PHASE2NCT00891527
Pilot Study Using Avastin and Gleevec to Treat the Progression of Intraluminal Pulmonary Vein Stenosis
Studying Pulmonary venoocclusive disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Boston Children's Hospital
- Principal Investigator
- Kathy J Jenkins, MD, MPHBoston Children's Hospital
- Intervention
- Bevacizumab (Avastin) and Imatinib Mesylate (Gleevec)(drug)
- Enrollment
- 50 target
- Eligibility
- All sexes
- Timeline
- 2008 – 2015
Study locations (1)
- Boston Childrens Hospital, Boston, Massachusetts, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00891527 on ClinicalTrials.gov